Age-associated-susceptibility to B cell autoimmunity in murine epidermolysis bullosa acquisita

Search results

• Active

  Identification of novel therapeutic targets for the treatment of autoantibody-induced tissue pathology in pemphigus

  Hundt, J. (Principal Investigator (PI)) & Ludwig, R. (Principal Investigator (PI))

  01.01.22 → 31.12.26

  Project: DFG Projects › DFG Individual Projects

  • Autoantibody 100%
  • Pemphigus 100%
  • Rituximab 50%
  • Keratinocyte 50%
  • Phosphotransferase 50%

• CRC 1526, PANTAU: Pathomechanisms of Antibody-mediated Autoimmunity

  Sadik, C. (Speaker, Coordinator), Zillikens, D. (Speaker, Coordinator), Scheffold, A. (Principal Investigator (PI)), Schmidt, E. (Principal Investigator (PI)), Heine, G. (Principal Investigator (PI)), Manz, R. (Principal Investigator (PI)), Köhl, J. (Principal Investigator (PI)), Ludwig, R. (Principal Investigator (PI)), Peipp, M. (Principal Investigator (PI)), Hammers, M. C. (Principal Investigator (PI)), Verschoor, A. (Principal Investigator (PI)), Karsten, C. (Principal Investigator (PI)), Nimmerjahn, F. (Principal Investigator (PI)), Hutloff, A. (Principal Investigator (PI)), Ibrahim, S. (Principal Investigator (PI)), Wettschureck, N. (Principal Investigator (PI)), Bieber, K. (Principal Investigator (PI)), Schilf, P. (Principal Investigator (PI)), Vaeth, M. (Principal Investigator (PI)), Hirose, M. (Principal Investigator (PI)), Vaeth, M. (Principal Investigator (PI)), Baines, J. F. (Principal Investigator (PI)), Bacher, P. (Principal Investigator (PI)), Hoffmann, M. (Principal Investigator (PI)), Busch, H. S. (Principal Investigator (PI)), Höppner, M. (Principal Investigator (PI)), Becker, M. (Principal Investigator (PI)), Holtsche, M. M. (Principal Investigator (PI)), Fähnrich, A. (Principal Investigator (PI)), Szymczak, S. (Principal Investigator (PI)), Murthy, S. (Principal Investigator (PI)) & Lux, A. (Principal Investigator (PI))

  01.01.22 → …

  Project: DFG Projects › DFG Joint Research: Collaborative Research Center/ Transregios

  • Bullous Pemphigoid 100%
  • Autoantibody 92%
  • Pemphigoid 71%
  • Pemphigus 60%
  • Autoimmune Disease 55%

• DFG Research Training Group RTG 2633: Defining and Targeting Autoimmune Pre-Disease

  Ludwig, R. (Principal Investigator (PI)), Bieber, K. (Principal Investigator (PI)), Busch, H. S. (Principal Investigator (PI)), Ehlers, M. (Principal Investigator (PI)), Hundt, J. (Principal Investigator (PI)), Kalies, K. (Principal Investigator (PI)), Karsten, C. (Principal Investigator (PI)), König, I. R. (Principal Investigator (PI)), Köhl, J. (Principal Investigator (PI)), Lamprecht, P. (Principal Investigator (PI)), Lange, T. (Principal Investigator (PI)), Manz, R. (Principal Investigator (PI)), Petersen, F. (Principal Investigator (PI)), Raasch, W. (Principal Investigator (PI)), Riemekasten, G. (Principal Investigator (PI)), Sadik, C. (Principal Investigator (PI)), Schmidt, E. (Principal Investigator (PI)) & Yu, X. (Principal Investigator (PI))

  01.01.21 → …

  Project: DFG Projects › DFG Joint Research: Research Training Groups

  • Autoimmune Disease 100%
  • Autoimmunity 85%
  • Pemphigus 85%
  • Pemphigoid 85%
  • Mediator 85%